Telehealth
Maternal Health
Health Care Workforce
Social Determinants of Health
Health Disparities and Health Equity
Healthcare worker safety
Consolidation and competition in healthcare
Healthcare funding
Community Project Funding
PBM Policy
Prior authorization policy
Valid Act
Medicare Lab Funding
GME Funding; Immigration policy
Medicare dependent hospitals
NIH funding
CDC Funding
AHRQ Funding
No Surprises Act Implementation
PAHPA Reauthorization
Post-acute and home health care payments
Tele-home health
Value based health care
Medicare Payment Policy
Medicare Shared Savings Program
340B
Tax exempt hospitals
Medicare Advantage
SAVE ACT (S. 2768)
Funding for trauma informed care and domestic violence programs
Drug Shortages
Lower Cost More Transparency Act
Medicare physician pay issues
Bonus payments for alternative payment models
Nurse Faculty Shortage Reduction Act (S. 2815)
Victims of Crime Act
Hospital at Home
Lab developed tests
Nursing education reimbursement
Duration: January 18, 2022
to
present
General Issues: Health Issues , Medicare/Medicaid , Budget/Appropriations
Spending: about $360,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2022: House of Representatives, U.S. Senate
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
John V. Drzewicki
Deputy chief of staff, Rep. John Katko; Legislative director, Rep. Scott Perry; Senior legislative assistant, Rep. Scott Perry; Legislative assistant, Rep. Steve Austria; Legislative correspondent, Rep. Steve Austria
Staff assistant, Rep. Steve Austria; Policy Advisor, US House of Representatives; Policy Director, US House of Representatives
Ilisa Halpern Paul
n/a
Jodie Curtis
n/a
Laura Hanen
n/a
Jennifer McBride
n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Venable LLP lobbied for Advocate Health , earning $40,000. The report was filed on April 22.
Original Filing: 301574314.xml
Lobbying Issues
Telehealth
Maternal Health
Health Care Workforce
Social Determinants of Health
Health Disparities and Health Equity
Healthcare worker safety
Consolidation and competition in healthcare
Healthcare funding
Community Project Funding
PBM Policy
Prior authorization policy
Valid Act
Medicare Lab Funding
GME Funding; Immigration policy
Medicare dependent hospitals
NIH funding
CDC Funding
AHRQ Funding
No Surprises Act Implementation
PAHPA Reauthorization
Post-acute and home health care payments
Tele-home health
Value based health care
Medicare Payment Policy
Medicare Shared Savings Program
340B
Tax exempt hospitals
Medicare Advantage
SAVE ACT (S. 2768)
Funding for trauma informed care and domestic violence programs
Drug Shortages
Lower Cost More Transparency Act
Medicare physician pay issues
Bonus payments for alternative payment models
Nurse Faculty Shortage Reduction Act (S. 2815)
Victims of Crime Act
Hospital at Home
Lab developed tests
Nursing education reimbursement
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2023
In Q4, Venable LLP lobbied for Advocate Health , earning $40,000. The report was filed on Jan. 20.
Original Filing: 301533828.xml
Lobbying Issues
Telehealth
Maternal Health
Health Care Workforce
Social Determinants of Health
Health Disparities and Health Equity
Healthcare worker safety
Consolidation and competition in healthcare
Healthcare funding
Community Project Funding
PBM Policy
Prior authorization policy
Valid Act
Medicare Lab Funding
GME Funding; Immigration policy
Medicare dependent hospitals
NIH funding
CDC Funding
AHRQ Funding
No Surprises Act Implementation
PAHPA Reauthorization
Post-acute and home health care payments
Tele-home health
Value based health care
Medicare Payment Policy
Medicare Shared Savings Program
340B OPPS payment restoration
Tax exempt hospitals
Medicare Advantage
SAVE ACT (S. 2768)
Funding for trauma informed care and domestic violence programs
Drug Shortages
Lower Cost More Transparency Act
Medicare physician pay issues
Bonus payments for alternative payment models
Nurse Faculty Shortage Reduction Act (S. 2815)
Victims of Crime Act
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2023
In Q3, Venable LLP lobbied for Advocate Health , earning $40,000. The report was filed on Oct. 20, 2023.
Original Filing: 301514343.xml
Lobbying Issues
Telehealth; Maternal Health; Health Care Workforce; Social Determinants of Health; Health Disparities and Health Equity; Healthcare worker safety; Consolidation and competition in healthcare; Healthcare funding; Community Project Funding; PBM Policy; Prior authorization policy; Valid Act; Medicare Lab Funding; GME Funding; Immigration policy; Medicare dependent hospitals; NIH funding; CDC Funding; AHRQ Funding; No Surprises Act Implementation; PAHPA Reauthorization; Post-acute and home health care payments; Tele-home health; Value based health care; Medicare Payment Policy; Medicare Shared Savings Program; 340B OPPS payment restoration; Tax exempt hospitals; Medicare advantage; Save Act; Funding for trauma informed care and domestic violence programs; Drug Shortages; Lower Cost More Transparency Act
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2023
In Q2, Venable LLP lobbied for Advocate Health , earning $40,000. The report was filed on July 20, 2023.
Original Filing: 301486954.xml
Lobbying Issues
Telehealth; Maternal Health; Health Care Workforce; Social Determinants of Health; Health Disparities and Health Equity; Healthcare worker safety; Consolidation and competition in healthcare; Healthcare funding; Community Project Funding; PBM Policy; Prior authorization policy; Medicaid/CHIP funding; MACRA Reform; Valid Act; Medicare Lab Funding; ACO Reach; GME Funding; Tax credits to healthcare workers; Immigration policy; Medicare dependent hospitals; Critical Access Hospitals; FQHCs; NIH funding; CDC Funding; AHRQ Funding; No Surprises Act Implementation; PAHPA Reauthorization; Hospital at home; EMTALA; Provider Relief Fund; Fraud and Abuse Law Modernization; Cyber security; Post-acute and home health care payments; Tele-home health; Value based health care; Medicare Payment Policy; Medicare Shared Savings Program; 340B OPPS payment restoration; Tax exempt hospitals; Patient safety; Medicare advantage
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2023
In Q1, Venable LLP lobbied for Advocate Health f/k/a Advocate Aurora Health , earning $40,000. The report was filed on April 20, 2023.
Original Filing: 301465491.xml
Lobbying Issues
340 B; Telehealth; Maternal Health; Declaration of Public Health Emergency; Health Care Workforce; Health disparities; Social Determinants of Health; Health Disparities and Health Equity; Healthcare worker safety; Consolidation in healthcare; Healthcare funding; Community Project Funding; PBM Policy; Prior authorization policy; Medicaid/CHIP funding; MACRA Reform; Valid Act; Medicare Lab Funding; ACO Reach; GME Funding; Tax credits to healthcare workers; Immigration policy; Medicare dependent hospitals; Critical Access Hospitals; FQHCs; NIH funding; CDC Funding; AHRQ Funding; No Surprises Act Implementation; PAHPA Reauthorization; Hospital at home; EMTALA; Provider Relief Fund; Fraud and Abuse Law Modernization; Cyber security; Post-acute and home health care payments; Tele-home health; Value based health care; Medicare Payment Policy; Medicare Shared Savings Program; Sequestration; Health Equity; 340B OPPS payment restoration
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2022
In Q4, Venable LLP lobbied for Advocate Aurora Health , earning $40,000. The report was filed on Jan. 19, 2023.
Original Filing: 301435795.xml
Lobbying Issues
Post-acute and home health care payments; Telehealth policy; Tele-home health; Value based health care; Medicare Payment Policy; Medicare Shared Savings Program; Sequestration; Home Health and Home Based Care; Health Equity; Social Determinants of Health; Workforce; H.R. 4587 - The Value in Health Care Act; H.R. 4449 - Pathways to Health Careers Act; S. 4067 - John Lewis Equality in Medicare and Medicaid Treatment Act; H.R. 5067/S. 2652 - Preserving Patient Access to Home Infusion Act; H.R. 8581/S. 4605 - Preserving Access to Home Health Act; H.R. 5514/S. 2562 - Choose Home Care Act; Antibiotics infused in home setting; S. 2565 - Expanding Access to Palliative Care Act; PAYGO sequester cuts; Physician fee schedule; Home health cuts; Home health; Telehealth waivers; 340B OPPS payment restoration; APM Bonus Extensions; S.4449/H.R.8188 - Saving Access to Laboratory Services Act.
Lobbying Issues
340 B; Telehealth; Maternal Health; Declaration of Public Health Emergency; Health Care Workforce; Health disparities; Social Determinants of Health; Health Disparities and Health Equity; H.Res.909 - Healthcare Worker Safety; H.R. 7961 - Safety From Violence for Healthcare Employees Act; Healthcare worker safety; Consolidation in healthcare; Healthcare workforce.
Lobbying Issues
Health care workforce funding; Community project funding.
3rd Quarter, 2022
In Q3, Venable LLP lobbied for Advocate Aurora Health , earning $40,000. The report was filed on Oct. 19, 2022.
Original Filing: 301410354.xml
Lobbying Issues
Post-acute and home health care payments; Telehealth policy; Tele-home health; Value based health care; Medicare Payment Policy; Medicare Shared Savings Program; Sequestration; Home Health and Home Based Care; Health Equity; Social Determinants of Health; Workforce; H.R. 4587 - The Value in Health Care Act; H.R. 4449 - Pathways to Health Careers Act; S. 4067 - John Lewis Equality in Medicare and Medicaid Treatment Act; H.R. 5067/S. 2652 - Preserving Patient Access to Home Infusion Act; H.R. 8581/S. 4605 - Preserving Access to Home Health Act; H.R. 5514/S. 2562 - Choose Home Care Act; Antibiotics infused in home setting; S. 2565 - Expanding Access to Palliative Care Act; PAYGO sequester cuts; Physician fee schedule; Home health cuts; Home health; Telehealth waivers; 340B OPPS payment restoration.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
340 B; Telehealth; Maternal Health; Declaration of Public Health Emergency; Health Care Workforce; Health disparities; Social Determinants of Health; Health Disparities and Health Equity; H.Res.909 - Healthcare Worker Safety; H.R. 7961 - Safety From Violence for Healthcare Employees Act; Healthcare worker safety; Consolidation in healthcare.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health care workforce funding; Community project funding.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2022
In Q2, Venable LLP lobbied for Advocate Aurora Health , earning $40,000. The report was filed on July 19, 2022.
Original Filing: 301387674.xml
Lobbying Issues
Post-acute and home health care payments; Telehealth policy; Tele-home health; Value based health care; Medicare Payment Policy; Medicare Shared Savings Program; Medicaid Coverage of Post-Partum Care; Sequestration; Home Health and Home Based Care; Health Equity; Social Determinants of Health; Consolidation in health care; Workforce; H.R. 4587 - The Value in Health Care Act; Provider Relief Fund; COVID length of stay; H.R. 4449 - Pathways to Health Careers Act; S. 4067 - John Lewis Equality in Medicare and Medicaid Treatment Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
340 B; Telehealth; Maternal Health; Declaration of Public Health Emergency; Health Care Workforce; Title VIII Nursing Workforce Development Programs; Health disparities; Provider Relief Fund; COVID Relief Packages; Social Determinants of Health; Health Disparities and Health Equity; H.Res.909 - Healthcare Worker Safety; H.R. 7961 - SAVE Act; Healthcare worker safety.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
COVID-19 funding for hospitals and health systems; Health care workforce funding; Community project funding.
1st Quarter, 2022
In Q1, Venable LLP lobbied for Advocate Aurora Health , earning $40,000. The report was filed on April 20, 2022.
Original Filing: 301367416.xml
Lobbying Issues
Post-acute and home health care payments; Telehealth policy; Tele-home health; Value based health care; Medicare Payment Policy; Medicare Shared Savings Program; Medicaid Coverage of Post-Partum Care; Physician Fee Schedule Cut; Sequestration; Home Health and Home Based Care; Health Equity; Social Determinants of Health; Consolidation in health care; Workforce; H.R. 4587 - The Value in Health Care Act; Provider Relief Fund; COVID length of stay.
Lobbying Issues
340 B; Telehealth; Maternal Health; Declaration of Public Health Emergency; Health Care Workforce; Title VIII Nursing Workforce Development Programs; Health disparities; Provider Relief Fund; COVID Relief Packages; Social Determinants of Health; Health Disparities and Health Equity; H.Res.909 - Healthcare Worker Safety.
Lobbying Issues
COVID-19 funding for hospitals and health systems; Health care workforce funding; Community project funding.
1st Quarter, 2022
Venable LLP filed a lobbying registration on March 28, 2022 to represent Advocate Aurora Health, effective Jan. 18, 2022.
Original Filing: 301343039.xml
Issue(s) they said they’d lobby about: Medicare and Medicaid inpatient and outpatient policies; health care workforce; 340B drug pricing program; maternal health; health equity and health disparities; value-based care; telehealth; funding for health systems COVID relief .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate